Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Houston, Texas 77030


This study includes an interview with men who have selected "watchful waiting" or "active surveillance" for their localized prostate cancer, in lieu of active treatment (such as surgery or radiation). We hope to understand the educational and support needs of men on surveillance so that we can develop a new intervention that will improve quality of life for such men.

Study summary:

Interviews are conducted over the telephone and require approximately 90 minutes to complete. Men interviewed are compensated for their participation in the study.


Inclusion Criteria: - 1) male, - 2) 18 years or older, with biopsy-proven prostate cancer, - 3) diagnosed with localized disease within the last 24 months, - 4) have a telephone at the time of enrollment, - 5) have an address where they can receive study materials by mail (a street address or post office box), - 6) able to speak and understand English; - 7) have selected surveillance, rather than active treatment for his prostate cancer. Exclusion Criteria: - 1) female - 2) no diagnosis of localized prostate cancer - 3) completed or undergoing active treatment (e.g., surgery, radiotherapy, etc.) - 4) no phone or US mail address - 5) unwilling or unable to provide informed consent - 6) unable to speak and understand English



Primary Contact:

Principal Investigator
David M Latini, PhD
Baylor College of Medicine

Backup Contact:


Location Contact:

Houston, Texas 77030
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.